foxo4-dri senolytic 2024 animal model The disordered p53 transactivation domain is the target of FOXO4 and the compound foxo4-dri senolytic peptide mouse model
foxo4 dri senolytic peptide mouse model 2024 regulates endothelial cell senescence via the P53 signaling pathway Frontiers Senolytic Peptide FOXO4 DRI Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI 10mg vial Description RCpeptides Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway
Pay in 4 interest-free payments of $5.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



